[Neutron] MLZ offers rapid access for research on coronavirus SARS-CoV-2

[useroffice at mlz-garching.de]

Dear neutron users,


Researchers worldwide are trying to develop drugs or a vaccine against the coronavirus SARS-CoV-2. In view of the corona pandemic, the Heinz Maier-Leibnitz Zentrum (MLZ) also offers special access to measurements with neutrons, which can provide important insights into the behaviour of the virus.

Scientists who want to use neutrons to study the corona virus SARS-CoV-2 or the disease COVID-19 will have special and privileged access. They do not have to apply for measurement time through the usual channels. “Research on the coronavirus SARS-CoV-2 and on the disease COVID-19 currently has priority over all other applications for measurement time at the MLZ,” said Prof. Dr. Peter Müller-Buschbaum, Scientific Director of the FRMII.

That is why the MLZ has set up a rapid access for research on the coronavirus SARS-CoV-2 with immediate effect. Guest scientists should contact the MLZ User Office directly with their applications for measurement time via email:

useroffice at mlz-garching.de<mailto:useroffice at mlz-garching.de>

A scientific evaluation of the application will then take place as soon as possible.

The MLZ User Office Team
Dr. Ina Lommatzsch - Ramona Bucher

--
Technische Universität München
Forschungs-Neutronenquelle Heinz Maier-Leibnitz (FRM II)
User Office Heinz Maier-Leibnitz Zentrum (MLZ)
Lichtenbergstraße 1
D-85747 Garching
Phone: +49-(0)89.289.10794 - 11751
e-mail: useroffice at mlz-garching.de
web: mlz-garching.de/useroffice

--
Sorry for any cross-posting!
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://lists.neutronsources.org/pipermail/neutron/attachments/20200325/c1c931a6/attachment.htm>